FIELD: medicine.
SUBSTANCE: invention concerns medicine, namely to paediatric gastroenterology. To diagnose the primary form of hypercholesterolemia in infants and preschoolers with gastroenterological diseases, total cholesterol level and homocysteine level are determined by the biochemical blood analysis. If total cholesterol exceeds 5.2 mm/l, while homocysteine is more than 8.5 mcM/l, primary hypercholesterolemia is diagnosed.
EFFECT: higher diagnostic accuracy of primary hypercholesterolemia in infants and preschoolers.
4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DIFFERENTIAL DIAGNOSTICS OF GASTROINTESTINAL FORM OF ALIMENTARY ALLERGY IN EARLY- AND PRE-SCHOOL-AGED CHILDREN | 2005 |
|
RU2287166C1 |
| DIAGNOSTIC TECHNIQUE FOR METABOLIC SYNDROME IN CHILDREN | 2013 |
|
RU2527847C1 |
| METHOD FOR EXAMINING CHILDREN WITH SUSPECTED ALAGILLE SYNDROME | 2016 |
|
RU2629828C1 |
| METHOD FOR PREDICTION OF RECURRENT ACETONEMIC VOMITING IN CHILDREN | 2011 |
|
RU2481576C1 |
| METHOD OF HYPERLIPIDEMIA TREATMENT | 1994 |
|
RU2054931C1 |
| MEDICINAL-PROPHYLAXIS AGENT OF CHOLESTEROL-REGULATING ACTION AND A METHOD OF DISEASE TREATMENT CAUSED CHOLESTEROL METABOLISM DAMAGE IN ORGANISM | 1993 |
|
RU2043111C1 |
| METHOD FOR PREDICTION OF PROBABILITY OF DEVELOPMENT OF ATHEROSCLEROSIS IN MINERS WITH ANTHRACOSILICOSIS | 2015 |
|
RU2595086C1 |
| METHOD FOR EXAMINATION OF CHILDREN WITH SUSPECTED PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS (PFIC) | 2016 |
|
RU2627615C1 |
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF HEPATOBILIARYSYSTEM MORPHOFUNCTIONAL DISTURBANCES IN NEWBORNS AND CHILDREN OF EARLY AGE FROM PERINATAL RISK GROUP | 2009 |
|
RU2393775C1 |
| METHOD OF CHOLESTEROL METABOLISM DETERMINATION | 0 |
|
SU1731173A1 |
